A clinical trial has found no significant differences between the use of carotid-artery stenting and carotid endarterectomy over a period of five years for the prevention of strokes in asymptomatic patients with serious narrowing of the carotid artery.
The first two patients in the European Peregrine system post-market study have been treated by Wojtek Wojakowski and Mariusz Hochul in Poland, Ablative Solutions has announced.
More than 250,000 patients have been treated with the Gore Excluder abdominal aortic aneurysm (AAA) endoprosthesis, the company has announced. This marks a significant milestone for the device, which received CE mark in 1997, and US Food and Drug Administration (FDA) approval in 2002.
A 12-month update on a study investigating the use of the Absorb drug-eluting scaffold (Abbott) in below-the-knee arteries (ABSORB BTK) indicates that bioresorbable vascular stents can achieve good immediate angiographic results and promising 12-month patency.
Peripheral artery disease patients who undergo endovascular treatment may have a lower risk of major and life-threatening bleeding events and a lower risk or restenosis or occlusion when treated with edoxaban and aspirin, rather than with clopidogrel and aspirin, according to a new proof of concept study.
Two cases have been successfully completed using the AorFit (Aortica) system to support simplified fenestrated endovascular aneurysm repair (FEVAR). The surgeries were performed by Benjamin Starnes, chief of Vascular Surgery, University of Washington, USA, as part of his physician-sponsored investigational device exemption study.
Huntleigh has launched the Dopplex ankle and toe pressure (ATP) kit. This comprises the company’s DMX Doppler, probes and accessories to aid the vascular, diabetic or lymphatic specialist with the assessment of arterial disease and neuropathy.
Huntleigh has launched the Dopplex DMX digital vascular Doppler. According to a company release, this Doppler combines audio clarity and a visual representation of waveforms with high performance probe sensitivity.
Merit Medical Systems has purchased the HeRO graft device and related assets from CryoLife.
The Lutonix 035 drug-coated balloon (DCB) percutaneous transluminal angioplasty catheter (Bard) has been featured in a series of podium and special session presentations during the Leipzig International Course (LINC), Leipzig, Germany. According to a Bard release, these presentations have demonstrated continued, confirmatory Lutonix DCB clinical data.
Medtronic and Sanford Health announced on 9 February 2016 the first patient enrolled in a clinical study using the Medtronic Valiant thoracoabdominal aortic aneurysm stent graft for minimally invasive repair of thoracoabdominal aortic aneurysms.
At the 2016 Leipzig Interventional Course meeting (LINC; 26–29 January, Leipzig, Germany), Michael R. Jaff, Boston, USA, discussed the challenges facing intervention for deep vein thrombosis and pulmonary embolism, and when using an interventional approach may be preferable.
ArtVentive Medical has announced enrolment in the ongoing OCCLUDE post-market surveillance study. This study aims to further the use of the EOS endoluminal occlusion system for the treatment of venous and arterial cases in which precise placement and immediate, efficient vessel embolisation are paramount.
Cook Medical has initiated a voluntary recall of 360 specific lots of single lumen central venous catheters and pressure monitoring sets and trays due to catheter tip fracture and/or separation.
Jens Ricke, professor of Radiology at the University of Magdeburg, has announced that the palliative cohort of the pan-European SORAMIC study he co-directs with Peter Malfertheiner has reached its enrolment target of 420 patients with unresectable hepatocellular carcinoma.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos